| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 45.845 | 70.541 | 89.466 | 109.978 | 130.626 | 77.730 | 110.111 | 136.569 | 165.634 | 185.118 |
| Total Income - EUR | 45.845 | 96.149 | 94.572 | 109.978 | 130.626 | 80.116 | 110.111 | 146.461 | 166.821 | 185.824 |
| Total Expenses - EUR | 53.986 | 71.748 | 81.976 | 95.948 | 116.268 | 78.621 | 101.356 | 121.860 | 145.299 | 173.328 |
| Gross Profit/Loss - EUR | -8.140 | 24.400 | 12.596 | 14.030 | 14.358 | 1.495 | 8.754 | 24.601 | 21.522 | 12.496 |
| Net Profit/Loss - EUR | -9.516 | 23.439 | 11.631 | 12.921 | 13.030 | 1.012 | 7.705 | 23.240 | 20.033 | 10.713 |
| Employees | 4 | 5 | 5 | 6 | 7 | 6 | 5 | 5 | 5 | 5 |
Check the financial reports for the company - Biosab Com Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 5.429 | 4.065 | 2.793 | 1.662 | 843 | 263 | 36 | 668 | 4.455 | 4.376 |
| Current Assets | 300 | 2.228 | 10.431 | 24.939 | 33.536 | 27.751 | 30.258 | 29.463 | 42.460 | 51.180 |
| Inventories | 0 | 266 | 189 | 270 | 332 | 125 | 112 | 173 | 349 | 292 |
| Receivables | 76 | 0 | 5 | 13 | 1.029 | 0 | -4.399 | 56 | 932 | 276 |
| Cash | 223 | 1.962 | 10.237 | 24.656 | 32.175 | 27.626 | 34.545 | 29.233 | 41.178 | 50.613 |
| Shareholders Funds | -25.960 | -2.257 | 9.412 | 22.161 | 29.704 | 24.633 | 26.233 | 25.221 | 41.538 | 48.038 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 31.689 | 8.550 | 3.812 | 4.440 | 4.675 | 3.380 | 4.060 | 4.909 | 5.376 | 7.519 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5610 - 5610" | |||||||||
| CAEN Financial Year |
5610
|
|||||||||
Comments - Biosab Com Srl